446 related articles for article (PubMed ID: 31669416)
1. The impact of a pharmacist-extender training program to improve pneumococcal vaccination rates within a community chain pharmacy.
Percy JN; Crain J; Rein L; Hohmeier KC
J Am Pharm Assoc (2003); 2020; 60(1):39-46. PubMed ID: 31669416
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist and pharmacy intern perceptions of adolescent vaccination administration.
McCauley LM; Lake LM; Madison NR; Huntsman RE; Baker CM
J Am Pharm Assoc (2003); 2020; 60(3S):S7-S12.e1. PubMed ID: 32359813
[TBL] [Abstract][Full Text] [Related]
3. Implementation of technician-driven medication therapy management program in community pharmacies.
Burnside TPT; Scott NJ; Smith MG
J Am Pharm Assoc (2003); 2019; 59(4S):S156-S160.e2. PubMed ID: 31326039
[TBL] [Abstract][Full Text] [Related]
4. Exploring the early phase of implementation of a vaccine-based clinical decision support system in the community pharmacy.
Frederick KD; Gatwood JD; Atchley DR; Rein LJ; Ali SG; Brookhart AL; Crain J; Hagemann TM; Ramachandran S; Chiu CY; Hohmeier KC
J Am Pharm Assoc (2003); 2020; 60(6):e292-e300. PubMed ID: 32389555
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study.
Hattingh HL; Sim TF; Parsons R; Czarniak P; Vickery A; Ayadurai S
BMJ Open; 2016 Sep; 6(9):e011948. PubMed ID: 27650763
[TBL] [Abstract][Full Text] [Related]
6. Facilitating pneumococcal vaccination among high-risk adults: Impact of an assertive communication training program for community pharmacists.
Gatwood J; Renfro C; Hagemann T; Chiu CY; Kapan S; Frederick K; Hohmeier KC
J Am Pharm Assoc (2003); 2021; 61(5):572-580.e1. PubMed ID: 33935021
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist impact on pneumococcal polysaccharide vaccination rates in patients with diabetes in a national grocery chain pharmacy.
Page A; Harrison A; Nadpara P; Goode JR
J Am Pharm Assoc (2003); 2020; 60(3S):S51-S55.e1. PubMed ID: 32192948
[TBL] [Abstract][Full Text] [Related]
8. National survey of pharmacy-based immunization services.
Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC
Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two training methods in community pharmacy: Project VACCINATE.
Lin JL; Bacci JL; Reynolds MJ; Li Y; Firebaugh RG; Odegard PS
J Am Pharm Assoc (2003); 2018; 58(4S):S94-S100.e3. PubMed ID: 29753630
[TBL] [Abstract][Full Text] [Related]
10. Enhancing pharmacy personnel immunization-related confidence, perceived barriers, and perceived influence: The We Immunize program.
Hastings TJ; Hohmann LA; Huston SA; Ha D; Westrick SC; Garza KB
J Am Pharm Assoc (2003); 2020; 60(2):344-351.e2. PubMed ID: 31735650
[TBL] [Abstract][Full Text] [Related]
11. Exploring the implementation of a novel optimizing care model in the community pharmacy setting.
Hohmeier KC; Desselle SP
J Am Pharm Assoc (2003); 2019; 59(3):310-318. PubMed ID: 30940516
[TBL] [Abstract][Full Text] [Related]
12. Patient and pharmacist perspectives on opioid misuse screening and brief interventions in community pharmacies.
Rao D; Ford JH; Shiyanbola OO
Addict Sci Clin Pract; 2024 Apr; 19(1):27. PubMed ID: 38589965
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
14. Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies.
Wang J; Ford LJ; Wingate L; Uroza SF; Jaber N; Smith CT; Randolph R; Lane S; Foster SL
J Am Pharm Assoc (2003); 2013; 53(1):46-53. PubMed ID: 23636155
[TBL] [Abstract][Full Text] [Related]
15. Assessing Pneumococcal Vaccination Availability in Under-Vaccinated Rural Counties: A Pharmacy Perspective.
Colorafi K; Panther S; McKeirnan K; Potyk D; McCarthy J; Temple S
Consult Pharm; 2018 Mar; 33(3):163-170. PubMed ID: 29720302
[TBL] [Abstract][Full Text] [Related]
16. Impact of the RxVaccinate program for pharmacy-based pneumococcal immunization: A cluster-randomized controlled trial.
Westrick SC; Owen J; Hagel H; Owensby JK; Lertpichitkul T
J Am Pharm Assoc (2003); 2016 Jan; 56(1):29-36.e1. PubMed ID: 26802917
[TBL] [Abstract][Full Text] [Related]
17. Supervising pharmacists' opinions about pharmacy technicians as immunizers.
Bertsch TG; McKeirnan KC; Frazier K; VanVoorhis L; Shin S; Le K
J Am Pharm Assoc (2003); 2019; 59(4):527-532. PubMed ID: 31036525
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study.
Doucette WR; Kreling DH; Schommer JC; Gaither CA; Mott DA; Pedersen CA
J Am Pharm Assoc (2003); 2006; 46(3):348-55. PubMed ID: 16739756
[TBL] [Abstract][Full Text] [Related]
19. Exploring pharmacists' perceptions regarding influenza and streptococcal testing within a chain pharmacy.
Dulaney K; Hohmeier K; Fisher C; Cardosi L; Wasson M
J Am Pharm Assoc (2003); 2018; 58(4):438-441.e1. PubMed ID: 29691199
[TBL] [Abstract][Full Text] [Related]
20. What predicts medication therapy management completion rates? The role of community pharmacy staff characteristics and beliefs about medication therapy management.
Adeoye OA; Lake LM; Lourens SG; Morris RE; Snyder ME
J Am Pharm Assoc (2003); 2018; 58(4S):S7-S15.e5. PubMed ID: 29731422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
